IXICO

IXICO is a London-based imaging contract research organisation providing end-to-end neuroimaging services to biopharmaceutical companies conducting clinical trials in neurological diseases.

The company collects, manages, and analyses MRI, PET, and SPECT imaging data from global trial sites, generating AI-driven biomarker measurements used as clinical endpoints for eligibility, safety, and efficacy assessments.

Therapeutic focus areas include Alzheimer's, Huntington's, Parkinson's, and multiple sclerosis.